Correlation Between Ensysce Biosciences and Panbela Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ensysce Biosciences and Panbela Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ensysce Biosciences and Panbela Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ensysce Biosciences and Panbela Therapeutics, you can compare the effects of market volatilities on Ensysce Biosciences and Panbela Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ensysce Biosciences with a short position of Panbela Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ensysce Biosciences and Panbela Therapeutics.

Diversification Opportunities for Ensysce Biosciences and Panbela Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Ensysce and Panbela is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Ensysce Biosciences and Panbela Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Panbela Therapeutics and Ensysce Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ensysce Biosciences are associated (or correlated) with Panbela Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Panbela Therapeutics has no effect on the direction of Ensysce Biosciences i.e., Ensysce Biosciences and Panbela Therapeutics go up and down completely randomly.

Pair Corralation between Ensysce Biosciences and Panbela Therapeutics

If you would invest  826.00  in Ensysce Biosciences on October 23, 2024 and sell it today you would lose (26.00) from holding Ensysce Biosciences or give up 3.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy5.26%
ValuesDaily Returns

Ensysce Biosciences  vs.  Panbela Therapeutics

 Performance 
       Timeline  
Ensysce Biosciences 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ensysce Biosciences are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Ensysce Biosciences exhibited solid returns over the last few months and may actually be approaching a breakup point.
Panbela Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Panbela Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Panbela Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Ensysce Biosciences and Panbela Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ensysce Biosciences and Panbela Therapeutics

The main advantage of trading using opposite Ensysce Biosciences and Panbela Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ensysce Biosciences position performs unexpectedly, Panbela Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Panbela Therapeutics will offset losses from the drop in Panbela Therapeutics' long position.
The idea behind Ensysce Biosciences and Panbela Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk